Insulin pumps may outperform insulin injections

Insulin, Pump, Infusion Set and Reservoir from Shutterstock
Insulin, Pump, Infusion Set and Reservoir from Shutterstock
Hdc Photo

Insulin pumps provide better blood sugar control for adults with diabetes than multiple daily insulin injections, a new study says.

Insulin pumps are small devices that are worn by patients and deliver constant amounts of insulin to the body through a catheter placed under the skin.

The multicentre, international study was funded by medical device maker Medtronic and included 331 people aged 30 to 75. All of the patients had poorly controlled type 2 diabetes and were using multiple daily injections of insulin to control their blood sugar levels.
Read: Control blood sugar with aerobic/strength training

The patients were randomly assigned to either continue using injections or to switch to an insulin pump.

Target range
After six months, patients who used the insulin pumps had a much greater reduction in average blood sugar levels than those who used injections, the study found. According to the researchers, twice as many patients in the pump group reached the blood sugar control target range (55 percent vs. 28 percent).

By the end of the study, patients in the pump group required a 20 percent lower daily dose of insulin than those in the injection group. Patients in the pump group also averaged nearly three hours less per day with high blood sugar than those in the injection group, the team reported in The Lancet.

According to the study, the amount of time people spent with extremely low blood sugar remained similarly low in both the pump and injection groups.
Read: Insulin pill on the cards for diabetics

"Our findings open up a valuable new treatment option for those individuals [who are] failing on current injection regimens," study author Yves Reznik, from the University of Caen Cote de Nacre Regional Hospital Centre in France, said in a journal news release. He believes that the devices "may also provide improved convenience, reducing the burden of dose tracking and scheduling, and decreasing insulin injection omissions."

Two experts in the United States weren't surprised by the findings.

Hurdles remain
"Many people with type 2 diabetes work hard to maximize the benefit of multiple daily injections of insulin but still struggle to keep their blood glucose values in target range," said Virginia Peragallo-Dittko, executive director of the Diabetes and Obesity Institute at Winthrop-University Hospital in Mineola, New York.

She said the study "supports use of an insulin pump as another safe and effective treatment option for this particular group of patients without promoting weight gain or hypoglycaemia."
Read: Sensor helps prevent nighttime hypoglycaemia

Dr. Gerald Bernstein directs the Diabetes Management Programme at the Friedman Diabetes Institute, part of Beth Israel Medical Centre in New York City. He believes that insulin pumps may be the future of diabetes care, but hurdles remain.

Because of insurance-related "inhibitors in our health care system", use of the devices "has not become common practice in the US," Bernstein said.

Diabetes educator
While daily self-injections have been the standard of care for decades, "for many [patients] where personal discipline plays a role, injections just don't do it," Bernstein said. Making the switch to an insulin pump also means that "you also need a sophisticated diabetes educator and pump trainer," he added.

However, Bernstein believes that "the future is bright – pump and continuous monitor use is increasing, which should mean a reduction in price. All of the effort is to improve quality of life, productivity and reduce the risk for complications."

More information:

The American Diabetes Association has more about insulin pumps.

Read more:
UKZN scientists develop a new diabetes controlling skin patch

Inhaled medication Afrezza approved to treat diabetes

Nanotechnology to help fight diabetes

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Nkosazana Dlamini-Zuma has got it in the bag
7% - 828 votes
I foresee a second term for Cyril Ramaphosa
83% - 9523 votes
Don’t discount a Zweli Mkhize win
10% - 1114 votes
Rand - Dollar
Rand - Pound
Rand - Euro
Rand - Aus dollar
Rand - Yen
Brent Crude
Top 40
All Share
Resource 10
Industrial 25
Financial 15
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.